Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content. This blocks access to the RELATIVITY-047 study details and related information.
    Difference
    18%
    Check dated 2026-09-23T21:53:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.6.6 to v3.7.0, indicating a newer version of the page. This is a maintenance update and does not modify the study content or results.
    Difference
    0.0%
    Check dated 2026-09-16T22:09:04.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The melanoma term, the related topics header, and the MedlinePlus Genetics link were removed. This reduces disease-specific context and access to a related health resource on the study page.
    Difference
    0.1%
    Check dated 2026-09-09T21:38:23.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Melanoma and related topics were added to the page, including MedlinePlus Genetics. The page revision was updated to v3.6.6, replacing the previous v3.6.5 entry.
    Difference
    0.1%
    Check dated 2026-09-02T19:05:27.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    - Deleted the explicit melanoma condition reference and related topics, including MedlinePlus Genetics, from the page content. This redefines how the study’s condition is presented and removes some consumer health cross-links from view.
    Difference
    0.1%
    Check dated 2026-08-19T19:38:27.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The revision has been updated from v3.6.4 to v3.6.5, and the related topics section now includes Melanoma and MedlinePlus Genetics, adding navigation/contextual links to the page.
    Difference
    0.1%
    Check dated 2026-08-12T20:54:20.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.